tetano
Editor, Senior Moderator
Nat Commun
. 2022 Sep 1;13(1):5135.
doi: 10.1038/s41467-022-32389-8.
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano[SUP] 1 [/SUP], Disha Bhavsar[SUP] 1 [/SUP], Gagandeep Singh[SUP] 1 [/SUP], Daniel Floda[SUP] 1 [/SUP], Komal Srivastava[SUP] 1 [/SUP], Charles Gleason[SUP] 1 [/SUP], PARIS Study Group; Juan Manuel Carreño[SUP] 1 [/SUP], Viviana Simon[SUP] 1 2 3 4 [/SUP], Florian Krammer[SUP] 5 6 [/SUP]
Collaborators, Affiliations
Abstract
Immune responses at the respiratory mucosal interface are critical to prevent respiratory infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) antibodies are induced by mRNA vaccination in humans. Here we analyze paired serum and saliva samples from patients with and without prior coronavirus disease 2019 (COVID-19) at multiple time points pre and post severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination. Our results suggest mucosal SIgA responses induced by mRNA vaccination are impacted by pre-existing immunity. Indeed, vaccination induced a minimal mucosal SIgA response in individuals without pre-exposure to SARS-CoV-2 while SIgA induction after vaccination was more efficient in patients with a history of COVID-19.
. 2022 Sep 1;13(1):5135.
doi: 10.1038/s41467-022-32389-8.
SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
Kaori Sano[SUP] 1 [/SUP], Disha Bhavsar[SUP] 1 [/SUP], Gagandeep Singh[SUP] 1 [/SUP], Daniel Floda[SUP] 1 [/SUP], Komal Srivastava[SUP] 1 [/SUP], Charles Gleason[SUP] 1 [/SUP], PARIS Study Group; Juan Manuel Carreño[SUP] 1 [/SUP], Viviana Simon[SUP] 1 2 3 4 [/SUP], Florian Krammer[SUP] 5 6 [/SUP]
Collaborators, Affiliations
- PMID: 36050304
- DOI: 10.1038/s41467-022-32389-8
Abstract
Immune responses at the respiratory mucosal interface are critical to prevent respiratory infections but it is unclear to what extent antigen specific mucosal secretory IgA (SIgA) antibodies are induced by mRNA vaccination in humans. Here we analyze paired serum and saliva samples from patients with and without prior coronavirus disease 2019 (COVID-19) at multiple time points pre and post severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination. Our results suggest mucosal SIgA responses induced by mRNA vaccination are impacted by pre-existing immunity. Indeed, vaccination induced a minimal mucosal SIgA response in individuals without pre-exposure to SARS-CoV-2 while SIgA induction after vaccination was more efficient in patients with a history of COVID-19.